| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26db05f349a12e10706b1e5ea02c860a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e56e251b16995c00ae4e04ef340bd758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac316c4307d2a84add2bae0328f607bd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2009-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38cb2d5aabe45811c044f5a8b98e0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca57c5c088e48af249855126050247f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7ce4492469afc021d8a5c99a66ce4d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_472974249f7a87656609ae6556a9e441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7489745727bac87e2107a4985e5cd297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c32aefecdf1090f237e059b95443117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd61b72c3cd7636d24bdd470360f33ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcece721d8043441527dfcdb6a8c8f93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc09abd09c4cedbc5748edba0d0ebbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d59a59804e32272cb121cfb50f139802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ab3067b8bc77f62f5e65f27e63146ac |
| publicationDate |
2011-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2292587-A1 |
| titleOfInvention |
Pharmaceutical composition for inhibiting the transcription factor inducible by hypoxia, modulators of pathological processes of angiogenesis, oncogenesis, inflammation, apoptosis, and cellular therapy |
| abstract |
The present invention is included in the field of pharmacology and medical chemistry and relates to novel molecules represented by general formula (I), especially the one called FM19G11, as well as to pharmaceutical compositions containing them. Said pharmacologically optimized compositions are capable of modulating and/or inhibiting the transcription of genes modulated by the hypoxia-inducible transcription factor (HIF) and which are directly and/or indirectly involved in pathological processes related to cancer, inflammation, tissue repair, stem cell differentiation and regenerative therapy. n The present invention also relates to a method for the synthesis of said molecules (I) and to the use thereof in the manufacture of a medicament for the treatment of the mentioned pathological processes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385399-B2 |
| priorityDate |
2008-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |